Sentinel lymph node biopsy in patients with cutaneous melanoma:: outcome after 3-year follow-up

被引：15
作者：
Mozzillo, N [1 ]
Caracò, C [1 ]
Chiofalo, MG [1 ]
Celentano, E [1 ]
Lastoria, S [1 ]
Botti, G [1 ]
Ascierto, PA [1 ]
机构：
[1] Natl Canc Inst, I-80131 Naples, Italy
来源：
EJSO | 2004年 / 30卷 / 04期
关键词：
cutaneous melanoma; lymphoscintigraphy; sentinel biopsy; lymphnode metastases;
D O I：
10.1016/j.ejso.2004.01.020
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Aims. The management of patients with cutaneous melanoma in the absence of lymph-node metastases is still controversial. The experience of the National Cancer Institute in Naples was analysed to evaluate the 3-year disease free survival and overall survival for all patients submitted to sentinel node biopsy (SNB). Methods. Data from 265 sentinel biopsies performed in the last five years were reviewed to determine the effect of the treatment on disease free survival and overall survival stratified the patients for node status and tumour ulceration. Results. Statistical analysis showed a 3-year survival advantage for sentinel node negative patients compared to sentinel node positive cases with a 88.4 and 72.9%, respectively (p < 0.05). Conclusions. SNB provides an accurate staging of nodal status in patients with melanoma in the absence of clinical evidence of metastases. Longer follow-up and final results from multicenter selective lymphadenectomy (MSLT) are needed to clarify the role of this procedure. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码：440 / 443
页数：4
相关论文
共 19 条
[1]   Sentinel lymph node biopsy to stage patients with cutaneous melanoma at the National Cancer Institute of Naples.: Results from 240 sentinel node biopsies [J].
Caracò, C ;
Chiofalo, MG ;
Niro, J ;
Ascierto, PA ;
Botti, G ;
Lastoria, S ;
Mozzillo, N .
TUMORI, 2002, 88 (03) :S12-S13
[2]  
CARACO C, 1997, J EXP CLIN CANC RES, V16, P244
[3]   Sentinel lymph node biopsy in cutaneous melanoma: The WHO Melanoma Program experience [J].
Cascinelli, N ;
Belli, F ;
Santinami, M ;
Fait, V ;
Testori, A ;
Ruka, W ;
Cavaliere, R ;
Mozzillo, N ;
Rossi, CR ;
MacKie, RM ;
Nieweg, O ;
Pace, M ;
Kirov, K .
ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (06) :469-474
[4]   Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: Review of a large single-institutional experience with an emphasis on recurrence [J].
Clary, BM ;
Brady, MS ;
Lewis, JJ ;
Coit, DG .
ANNALS OF SURGERY, 2001, 233 (02) :250-258
[5]   Improved staging of node-negative patients with intermediate to thick melanomas (&gt;1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy [J].
Dessureault, S ;
Soong, SJ ;
Ross, MI ;
Thompson, JF ;
Kirkwood, JM ;
Coit, DG ;
McMasters, KM ;
Balch, CM ;
Reintgen, D .
ANNALS OF SURGICAL ONCOLOGY, 2001, 8 (10) :766-770
[6]   Does the tumor status of the regional lymph nodes really matter in melanoma? [J].
Essner, R ;
Morton, DL .
ANNALS OF SURGICAL ONCOLOGY, 2001, 8 (10) :749-751
[7]   Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (≥4 mm) primary melanoma [J].
Gershenwald, JE ;
Mansfield, PF ;
Lee, JE ;
Ross, MI .
ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (02) :160-165
[8]   Prognosis of thick cutaneous melanoma [J].
Kim, SH ;
Garcia, C ;
Rodriguez, J ;
Coit, DG .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1999, 188 (03) :241-247
[9]   Sentinel lymph node biopsy for melanoma: Controversy despite widespread agreement [J].
McMasters, KM ;
Reintgen, DS ;
Ross, MI ;
Gershenwald, JE ;
Edwards, MJ ;
Sober, A ;
Fenske, N ;
Glass, F ;
Balch, CM ;
Coit, DG .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (11) :2851-2855
[10]   Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma - A multicenter trial [J].
Morton, DL ;
Thompson, JF ;
Essner, R ;
Elashoff, R ;
Stern, SL ;
Nieweg, OE ;
Roses, DF ;
Karakousis, CP ;
Mozzillo, N ;
Reintgen, D ;
Wang, HJ ;
Glass, EC ;
Cochran, AJ .
ANNALS OF SURGERY, 1999, 230 (04) :453-463
12